Hartford Investment Management CO Regeneron Pharmaceuticals, Inc. Transaction History

Hartford Investment Management CO

  • $2.99 Billion
  • Q3 2024

A detailed history of Hartford Investment Management CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 6,686 shares of REGN stock, worth $5.06 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
6,686
Previous 6,800 1.68%
Holding current value
$5.06 Million
Previous $7.15 Million 1.67%
% of portfolio
0.23%
Previous 0.25%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024
SELL
$1024.09 - $1201.76 $116,746 - $137,000
-114 Reduced 1.68%
6,686 $7.03 Million
Q2 2024

Aug 01, 2024
SELL
$883.2 - $1071.19 $24,729 - $29,993
-28 Reduced 0.41%
6,800 $7.15 Million
Q1 2024

Apr 17, 2024
SELL
$902.69 - $993.35 $352,951 - $388,399
-391 Reduced 5.42%
6,828 $6.57 Million
Q4 2023

Jan 23, 2024
SELL
$775.18 - $881.7 $74,417 - $84,643
-96 Reduced 1.31%
7,219 $6.34 Million
Q3 2023

Oct 16, 2023
SELL
$692.45 - $844.37 $204,272 - $249,089
-295 Reduced 3.88%
7,315 $6.02 Million
Q2 2023

Jul 19, 2023
SELL
$700.03 - $830.35 $1.04 Million - $1.23 Million
-1,483 Reduced 16.31%
7,610 $5.47 Million
Q1 2023

May 09, 2023
SELL
$680.49 - $826.97 $1.14 Million - $1.39 Million
-1,680 Reduced 15.59%
9,093 $7.47 Million
Q4 2022

Jan 20, 2023
SELL
$705.89 - $766.39 $40,235 - $43,684
-57 Reduced 0.53%
10,773 $7.77 Million
Q3 2022

Nov 02, 2022
SELL
$573.97 - $724.32 $14,349 - $18,108
-25 Reduced 0.23%
10,830 $7.46 Million
Q2 2022

Jul 22, 2022
BUY
$548.35 - $738.84 $139,280 - $187,665
254 Added 2.4%
10,855 $6.42 Million
Q1 2022

Apr 20, 2022
SELL
$595.12 - $698.43 $389,208 - $456,773
-654 Reduced 5.81%
10,601 $7.4 Million
Q4 2021

Feb 02, 2022
BUY
$543.48 - $670.97 $491,849 - $607,227
905 Added 8.74%
11,255 $7.11 Million
Q3 2021

Nov 01, 2021
SELL
$574.03 - $680.96 $1.12 Million - $1.33 Million
-1,954 Reduced 15.88%
10,350 $6.26 Million
Q2 2021

Jul 29, 2021
SELL
$472.8 - $558.54 $58,627 - $69,258
-124 Reduced 1.0%
12,304 $6.87 Million
Q1 2021

Apr 21, 2021
SELL
$446.73 - $548.2 $88,452 - $108,543
-198 Reduced 1.57%
12,428 $5.88 Million
Q4 2020

Feb 01, 2021
BUY
$478.3 - $607.98 $793,021 - $1.01 Million
1,658 Added 15.12%
12,626 $6.1 Million
Q3 2020

Oct 29, 2020
BUY
$544.75 - $658.21 $13,618 - $16,455
25 Added 0.23%
10,968 $6.14 Million
Q2 2020

Aug 04, 2020
BUY
$493.32 - $643.92 $1.12 Million - $1.47 Million
2,279 Added 26.3%
10,943 $6.83 Million
Q1 2020

Apr 24, 2020
BUY
$336.18 - $494.43 $111,275 - $163,656
331 Added 3.97%
8,664 $4.23 Million
Q4 2019

Jan 29, 2020
SELL
$274.13 - $376.51 $61,130 - $83,961
-223 Reduced 2.61%
8,333 $3.13 Million
Q3 2019

Oct 28, 2019
BUY
$273.46 - $318.39 $1,367 - $1,591
5 Added 0.06%
8,556 $2.37 Million
Q2 2019

Jul 25, 2019
BUY
$299.6 - $414.82 $19,773 - $27,378
66 Added 0.78%
8,551 $2.68 Million
Q1 2019

Apr 29, 2019
SELL
$372.08 - $439.57 $16,371 - $19,341
-44 Reduced 0.52%
8,485 $3.48 Million
Q4 2018

Feb 04, 2019
SELL
$335.82 - $403.04 $17,798 - $21,361
-53 Reduced 0.62%
8,529 $3.19 Million
Q3 2018

Nov 08, 2018
SELL
$351.14 - $408.51 $49,861 - $58,008
-142 Reduced 1.63%
8,582 $3.47 Million
Q2 2018

Jul 19, 2018
SELL
$284.6 - $344.99 $1.67 Million - $2.02 Million
-5,863 Reduced 40.19%
8,724 $3.01 Million
Q1 2018

Apr 24, 2018
SELL
$315.82 - $393.78 $386,247 - $481,592
-1,223 Reduced 7.74%
14,587 $5.02 Million
Q4 2017

Feb 12, 2018
SELL
$358.63 - $469.95 $237,413 - $311,106
-662 Reduced 4.02%
15,810 $5.94 Million
Q3 2017

Nov 13, 2017
BUY
$431.38 - $504.0 $7.11 Million - $8.3 Million
16,472
16,472 $7.37 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Hartford Investment Management CO Portfolio

Follow Hartford Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email